Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection (Q42995344)

12 November 2017

title

Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection (English)

1 reference

12 November 2017

1 reference

1 reference

Murakami T

1

1 reference

12 November 2017

Enomoto N

2

1 reference

12 November 2017

Kurosaki M

3

1 reference

12 November 2017

Izumi N

4

1 reference

12 November 2017

Marumo F

5

1 reference

12 November 2017

Sato C

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

12 November 2017

1 reference

12 November 2017

volume

30

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

1045-1053

1 reference

Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

There are two major types of hepatitis C virus in Japan

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

HCV genotypes in chronic hepatitis C and response to interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Variation in the hepatitis C virus NS5a region in relation to hypervariable region 1 heterogeneity during interferon treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

The "interferon sensitivity determining region" of hepatitis C virus is a stable sequence element

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

HCV NS5A mutations in Europeans infected by genotype 1b.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Differences in the hepatitis C virus genotypes in different countries

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Clinical backgrounds of the patients having different types of hepatitis C virus genomes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Hepatitis C genotypes: current trends and future implications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Genotypic analysis of hepatitis C virus in American patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

cDNA sequencing of the 5' noncoding region (5' NCR) to determine hepatitis C genotypes in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Evaluation of a reverse hybridization assay for genotyping of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300405

7 January 2021

Identifiers

DOI

10.1002/HEP.510300405

1 reference

12 November 2017

1 reference